Outcome after 5 years according to molecular response after induction (day 71) and consolidation (week 16)
Parameter . | Day 71 after induction . | P . | Week 16 after consolidation . | P . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N . | MolCR . | MolFail . | N . | MolCR . | MolFail . | |||||||
n . | % ± SD . | n . | % ± SD . | n . | % ± SD . | n . | % ± SD . | |||||
Standard risk | ||||||||||||
CCR | 434 | 335 | 69 ± 3 | 99 | 42 ± 6 | < .0001 | 424 | 335 | 74 ± 3 | 89 | 37 ± 6 | < .0001 |
CCR SCT excluded | 384 | 317 | 69 ± 3 | 67 | 32 ± 7 | <.0001 | 376 | 322 | 74 ± 3 | 54 | 13 ± 5 | < .0001 |
DFS | 434 | 335 | 62 ± 3 | 99 | 35 ± 6 | < .0001 | 424 | 335 | 68 ± 3 | 89 | 28 ± 5 | < .0001 |
DFS SCT excluded | 384 | 317 | 62 ± 3 | 67 | 27 ± 6* | < .0001 | 376 | 322 | 68 ± 3 | 54 | 11 ± 5 | < .0001 |
Overall survival | 434 | 335 | 80 ± 3 | 99 | 47 ± 6 | < .0001 | 424 | 335 | 81 ± 3 | 89 | 43 ± 6 | < .0001 |
Overall survival SCT excluded | 384 | 317 | 80 ± 3 | 67 | 38 ± 7 | < .0001 | 376 | 322 | 81 ± 3 | 54 | 31 ± 7 | < .0001 |
High risk | ||||||||||||
CCR | 145 | 72 | 78 ± 8 | 73 | 41 ± 7 | < .0001 | 80 | 49 | 75 ± 8 | 31 | 29 ± 12 | < .0001 |
CCR SCT excluded | 40 | 16 | 36 ± 26 | 24 | 21 ± 10 | .001 | 20 | 11 | 50 ± 35 | 9 | 19 ± 17 | < .0001 |
DFS | 145 | 72 | 66 ± 8 | 73 | 32 ± 6 | < .0001 | 80 | 49 | 64 ± 8* | 31 | 18 ± 8* | < .0001 |
DFS SCT excluded | 40 | 16 | 18 ± 15* | 24 | 6 ± 5* | .003 | 20 | 11 | 34 ± 26* | 9 | 11 ± 10* | .0009 |
Overall survival | 146 | 72 | 72 ± 8 | 74 | 49 ± 7 | .0005 | 80 | 49 | 71 ± 9 | 31 | 41 ± 10 | .003 |
Overall survival SCT excluded | 40 | 16 | 56 ± 17 | 24 | 21 ± 9 | .06 | 20 | 11 | 83 ± 15 | 9 | 44 ± 17 | NS |
Overall | ||||||||||||
CCR | 579* | 407 | 70 ± 3 | 172 | 39 ± 5 | < .0001 | 504 | 384 | 74 ± 3 | 120 | 35 ± 5 | < .0001 |
CCR SCT excluded | 424 | 333 | 68 ± 3 | 91 | 26 ± 6 | < .0001 | 396 | 333 | 74 ± 3 | 63 | 12 ± 5 | < .000 |
DFS | 579 | 407 | 63 ± 3 | 172 | 31 ± 4 | < .0001 | 504 | 384 | 67 ± 3 | 120 | 25 ± 5 | < .0001 |
DFS SCT excluded | 424 | 333 | 60 ± 3 | 91 | 20 ± 5 | < .0001 | 396 | 333 | 68 ± 3 | 63 | 10 ± 4 | < .0001 |
Overall survival | 580 | 407 | 79 ± 3 | 173 | 47 ± 5 | < .0001 | 504 | 384 | 80 ± 3 | 120 | 42 ± 5 | < .0001 |
Overall survival SCT excluded | 424 | 333 | 80 ± 3 | 91 | 36 ± 6 | < .0001 | 396 | 333 | 81 ± 3 | 63 | 33 ± 7 | < .0001 |
Parameter . | Day 71 after induction . | P . | Week 16 after consolidation . | P . | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
N . | MolCR . | MolFail . | N . | MolCR . | MolFail . | |||||||
n . | % ± SD . | n . | % ± SD . | n . | % ± SD . | n . | % ± SD . | |||||
Standard risk | ||||||||||||
CCR | 434 | 335 | 69 ± 3 | 99 | 42 ± 6 | < .0001 | 424 | 335 | 74 ± 3 | 89 | 37 ± 6 | < .0001 |
CCR SCT excluded | 384 | 317 | 69 ± 3 | 67 | 32 ± 7 | <.0001 | 376 | 322 | 74 ± 3 | 54 | 13 ± 5 | < .0001 |
DFS | 434 | 335 | 62 ± 3 | 99 | 35 ± 6 | < .0001 | 424 | 335 | 68 ± 3 | 89 | 28 ± 5 | < .0001 |
DFS SCT excluded | 384 | 317 | 62 ± 3 | 67 | 27 ± 6* | < .0001 | 376 | 322 | 68 ± 3 | 54 | 11 ± 5 | < .0001 |
Overall survival | 434 | 335 | 80 ± 3 | 99 | 47 ± 6 | < .0001 | 424 | 335 | 81 ± 3 | 89 | 43 ± 6 | < .0001 |
Overall survival SCT excluded | 384 | 317 | 80 ± 3 | 67 | 38 ± 7 | < .0001 | 376 | 322 | 81 ± 3 | 54 | 31 ± 7 | < .0001 |
High risk | ||||||||||||
CCR | 145 | 72 | 78 ± 8 | 73 | 41 ± 7 | < .0001 | 80 | 49 | 75 ± 8 | 31 | 29 ± 12 | < .0001 |
CCR SCT excluded | 40 | 16 | 36 ± 26 | 24 | 21 ± 10 | .001 | 20 | 11 | 50 ± 35 | 9 | 19 ± 17 | < .0001 |
DFS | 145 | 72 | 66 ± 8 | 73 | 32 ± 6 | < .0001 | 80 | 49 | 64 ± 8* | 31 | 18 ± 8* | < .0001 |
DFS SCT excluded | 40 | 16 | 18 ± 15* | 24 | 6 ± 5* | .003 | 20 | 11 | 34 ± 26* | 9 | 11 ± 10* | .0009 |
Overall survival | 146 | 72 | 72 ± 8 | 74 | 49 ± 7 | .0005 | 80 | 49 | 71 ± 9 | 31 | 41 ± 10 | .003 |
Overall survival SCT excluded | 40 | 16 | 56 ± 17 | 24 | 21 ± 9 | .06 | 20 | 11 | 83 ± 15 | 9 | 44 ± 17 | NS |
Overall | ||||||||||||
CCR | 579* | 407 | 70 ± 3 | 172 | 39 ± 5 | < .0001 | 504 | 384 | 74 ± 3 | 120 | 35 ± 5 | < .0001 |
CCR SCT excluded | 424 | 333 | 68 ± 3 | 91 | 26 ± 6 | < .0001 | 396 | 333 | 74 ± 3 | 63 | 12 ± 5 | < .000 |
DFS | 579 | 407 | 63 ± 3 | 172 | 31 ± 4 | < .0001 | 504 | 384 | 67 ± 3 | 120 | 25 ± 5 | < .0001 |
DFS SCT excluded | 424 | 333 | 60 ± 3 | 91 | 20 ± 5 | < .0001 | 396 | 333 | 68 ± 3 | 63 | 10 ± 4 | < .0001 |
Overall survival | 580 | 407 | 79 ± 3 | 173 | 47 ± 5 | < .0001 | 504 | 384 | 80 ± 3 | 120 | 42 ± 5 | < .0001 |
Overall survival SCT excluded | 424 | 333 | 80 ± 3 | 91 | 36 ± 6 | < .0001 | 396 | 333 | 81 ± 3 | 63 | 33 ± 7 | < .0001 |
MolCR indicates molecular complete response; molFail, molecular failure; CCR, continuous complete remission; SCT, stem cell transplantation; and DFS, disease-free survival.
Five years not reached.